These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16615535)

  • 61. Primary Epstein-Barr virus infection and thrombocytopenia during late infancy.
    Andiman WA
    J Pediatr; 1976 Sep; 89(3):435-8. PubMed ID: 182945
    [No Abstract]   [Full Text] [Related]  

  • 62. [Clinicopathologic significance of detecting Epstein-Barr virus small RNA].
    Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):321-3. PubMed ID: 16834903
    [No Abstract]   [Full Text] [Related]  

  • 63. The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus.
    Young NS; Baranski B; Kurtzman G
    Ann N Y Acad Sci; 1989; 554():75-80. PubMed ID: 2544123
    [No Abstract]   [Full Text] [Related]  

  • 64. EBV-reactivation and post-transplant lymphoproliferative disorder treated with rituximab.
    Dua V; Yadav SP
    Indian Pediatr; 2013 Mar; 50(3):345. PubMed ID: 23680617
    [No Abstract]   [Full Text] [Related]  

  • 65. HLA matching and posttransplant lymphoproliferative disease after lung transplantation.
    Bakker NA; Imhoff GW; Verschuuren EA; Veeger NJ; Hepkema BG
    Transplantation; 2005 Oct; 80(8):1134-5. PubMed ID: 16278599
    [No Abstract]   [Full Text] [Related]  

  • 66. [Epstein-Barr virus. Its participation in lymphoproliferative and anaplastic processes].
    Fejes M; Bachmann AE; Mochanko K
    Medicina (B Aires); 1978; 38(6 Pt 1):700-16. PubMed ID: 220495
    [No Abstract]   [Full Text] [Related]  

  • 67. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
    [No Abstract]   [Full Text] [Related]  

  • 68. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 69. [Immune response to Epstein-Barr virus].
    Kanegane H; Miyawaki T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():564-7. PubMed ID: 16615535
    [No Abstract]   [Full Text] [Related]  

  • 70. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conjunctival tumor caused by Epstein-Barr virus-related infectious mononucleosis: Case report and review of literature.
    Vaivanijkul J; Boonsiri K
    Orbit; 2017 Apr; 36(2):91-94. PubMed ID: 28388350
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Epstein-Barr virus].
    Tsurumi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
    [No Abstract]   [Full Text] [Related]  

  • 73. New oncologic associations for the Epstein-Barr virus.
    Gartner JG; Seemayer TA
    Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.